World
Sinovac vaccine efficacy 83.5pc according to Turkish university, reports Anadolu
Wednesday, 03 Mar 2021 5:13 PM MYT
ISTANBUL, March 3 — The Covid-19 vaccine developed by China’s Sinovac Biotech has an efficacy of 83.5 per cent based on final Phase III trials, Turkish state media quoted Hacettepe University as saying today.
Anadolu news agency also quoted the university as saying the vaccine prevented hospitalisation in 100 per cent of cases. — Reuters
You May Also Like